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Current biological studies have been advanced by the continuous development of robust,
accurate, and sensitive mass spectrometric technologies. The MALDI LTQ Orbitrap is a new
addition to the Orbitrap configurations, known for their high resolving power and accuracy.
This configuration provides features inherent to the MALDI source, such as reduced spectra
complexity, forgiveness to contaminants, and sample retention for follow-up analyses with
targeted or hypothesis-driven questions. Here we investigate its performance for characteriz-
ing the composition of isolated protein complexes. To facilitate the assessment, we selected
two well characterized complexes from Saccharomyces cerevisiae, Apl1 and Nup84. Manual and
automatic MS and MS/MS analyses readily resolved their compositions, with increased
confidence of protein identification compared with our previous reports using MALDI QqTOF
and MALDI IT. CID fragmentation of singly-charged peptides provided sufficient information
for conclusive identification of the isolated proteins. We then assessed the resolution, accuracy,
and sensitivity provided by this instrument in the context of analyzing the isolated protein
assemblies. Our analysis of complex mixtures of singly-charged ions up to m/z 4000 showed
that (1) the resolving power, inversely proportional to the square root of m/z, had over four
orders of magnitude dynamic range; (2) internal calibration led to improved accuracy, with an
average absolute mass error of 0.5 ppm and a distribution centered at 0 ppm; and (3)
subfemtomole sensitivity was achieved using both CHCA and DHB matrices. Additionally,
our analyses of a synthetic phosphorylated peptide in mixtures showed subfemtomole level of
detection using neutral loss scanning. (J Am Soc Mass Spectrom 2010, 21, 34–46) © 2010
Published by Elsevier Inc. on behalf of American Society for Mass SpectrometryIn recent years, mass spectrometry has acquired awell deserved pivotal role in biological studies.Mass spectrometric analyses of complex biological
samples have become an essential aspect in elucidating
cellular function. Frequently utilized mass spectrome-
ters include matrix-assisted laser desorption ionization
(MALDI) configurations, shown to be robust and valu-
able tools for analyzing the composition of isolated
protein complexes and larger assemblies (e.g., nuclear
pore complex [1, 2] or postsynaptic densities [3]. These
studies were made possible by the development of
MALDI mass spectrometers as tandem hybrid or mod-
ular configurations that provided access to the com-
bined strengths of various mass analyzers, such as
time-of-flight (TOF) [4, 5], quadrupole/time-of-flight
(Q-TOF) [6], QqTOF [7], TOF-TOF [8], and ion traps (IT)
[9]. For example, Krutchinsky and co-workers [10] have
described MALDI-QqTOF and MALDI-IT mass spec-
trometers as a modular instrument, allowing the anal-
ysis of complex protein mixtures by taking advantage
of the levels of resolution, accuracy (QqTOF), speed,
and sensitivity (IT). There are several features that make
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doi:10.1016/j.jasms.2009.08.026the use of MALDI configurations attractive, including
ease of use and forgiveness to contaminants. The re-
duced sample complexity, inherent to the MALDI-
generated singly-charged ions, provides the opportunity
of carrying out analyses on the majority of the observed
ions. While high-throughput automatic analyses are
frequently employed using these configurations, sam-
ple retention provides the option for follow-up analy-
ses, lowering the threshold of the initial level of detec-
tion. One well known limitation when using MALDI
configurations is that the fragmentation of singly-
charged ions is highly dependent on the amino acid
sequence, occurring preferentially at the C-terminus of
aspartyl and glutamyl residues and the N-terminus of
prolyl residues [11–13], making their implementation
less suitable for comprehensive sequencing. However, a
MALDI-quadrupole ion trap was shown to provide the
levels of detection necessary for observing the less
prominent fragments and, in certain situations, enough
information for de novo sequencing [14].
A new addition to the MALDI mass spectrometric
configurations, the MALDI LTQ Orbitrap XL [15] cou-
ples a vacuumMALDI source to a hybrid LTQ Orbitrap
[16]. Recent years have seen a rapid development and
wide-spread implementation of the Orbitrap mass an-
alyzer and its associated configurations [17–20]. Several
modifications to these ESI LTQ Orbitrap configurations,
Published online September 17, 2009
ass Spectrometry. Received July 10, 2009
Revised August 18, 2009
Accepted August 31, 2009
35J Am Soc Mass Spectrom 2010, 21, 34–46 MALDI LTQ ORBITRAP FOR PROTEIN ASSEMBLIESsuch as the integration of electron-transfer dissociation
[21], emerged to further extend performance [22] and
reach of applications. The introduction of the MALDI
LTQ Orbitrap XL [15] provides complementary merits
to those offered by ESI. Karas and co-workers have re-
cently reported its application, in conjunction with
acid hydrolysis, to analyzing RNA oligonucleotide se-
quences [23]. Here we describe the performance of a
MALDI LTQ Orbitrap configuration for elucidating the
composition of protein complexes isolated via rapid
immunoaffinity purifications on magnetic beads. To
aid the assessment, we selected two protein complexes
that we previously characterized using MALDI QqTOF
and MALDI-IT configurations, the yeast nuclear pore
Nup84 subcomplex and the yeast clathrin associated
protein complex AP-2 isolated via Apl1 [24]. We discuss
the utility of this instrument for studying the composi-
tion of protein complexes and assess the resolving
power, accuracy, and sensitivity from the perspective of
analyzing complex peptide mixtures.
Experimental
Cell Line Construction and Cell Culture
Saccharomyces cerevisiae yeast strains expressing Nup84
or Apl1 genomically tagged with protein A (PrA) or
enhanced green fluorescent protein (EGFP), respec-
tively, were grown to 2.0  107 cells/mL, harvested,
and frozen as previously described [24, 25]. The Nup84-
PrA strain was a kind gift from Michael P. Rout (The
Rockefeller University) and the Apl1-EGFP strain was
purchased from Invitrogen (Carlsbad, CA, USA). Cells
were harvested by centrifugation at 3000 rpm, washed
twice with PBS, weighed and suspended at 100 L/g
cell in freezing buffer [20 mM HEPES, pH 7.5, 1.2%
wt/vol polyvinyl-pyrrolidone (Sigma, St. Louis, MO,
USA), 1/100 vol/vol protease inhibitor cocktail
(Sigma)]. The resulting cell paste was frozen as small
pellets in liquid nitrogen as previously described [24].
Cell Cryogenic Disruption and Lysis
Two g Nup84-PrA and 6 g Apl1-EGFP yeast cells were
cryogenically disrupted using the Retsch MM301 Mixer
Mill (Retch, Newtown, PA, USA) by loading the cell
pellets into 25 mL stainless steel jars (Retch), each with
a 20 mm stainless steel grinding ball (McMaster, NJ,
USA). Approximately 90% efficiency of grinding, as
assessed by lightmicroscopy, was achieved using 10 steps
of 2.5 min at 30 Hz with intermittent cooling in liquid
nitrogen. The frozen cell powders were suspended in
optimized lysis buffers (Supplementary Table S1, which
can be found in the electronic version of this article) at 5
mL/g cell powder, homogenized for 10 s with a PT 10-35
Polytron (Kinematica, Bohemia, NY, USA), centrifuged
for 10 min at 5000 rpm at 4 °C. The supernatant fractions
were used for affinity purifications.Conjugation of Magnetic Beads with Antibodies
Custom anti-GFP rabbit polyclonal antibodies were
prepared and affinity-purified [24]. Purified rabbit IgG
(ICN Pharmaceutical, Costa Mesa, CA, USA) was used
for isolations of the PrA tag. M-270 epoxy magnetic
beads (Dynal; Invitrogen) were conjugated as previ-
ously described [24] with 5 g of anti-GFP antibodies or
10 g IgG per mg of beads; 8 mg of conjugated beads
were utilized for each immunoaffinity purification.
Immunoaffinity Purification
Conjugatedmagnetic beadswerewashed three timeswith
corresponding lysis buffers and incubated with the cell
lysates by gentle rotation at 4 °C for optimized periods of
time, 30 min for Nup84 and 1 h for Apl1. After six washes
with lysis buffer, the isolated protein complexes were
eluted from the beads with 700 L of a freshly-made 0.5 N
NH4OH, 0.5 mM EDTA solution by shaking for 20 min at
room temperature. The eluted fractions were frozen in
liquid nitrogen and dried using vacuum centrifugation
(Speed Vac Plus SC110A with gel pump GP110; Thermo
Scientific, Waltham, MA, USA). The dried samples were
suspended in 30 L LDS-PAGE buffer with reducing
agent (Invitrogen), incubated at 70 °C for 10 min with
agitation, alkylated with 100 mM iodoacetamide at
room temperature in the dark for 30 min, and resolved
by 1-D gel electrophoresis on 4–12% NuPAGE Novex
Bis-Tris gel (Invitrogen). The gels were stained with
SimplyBlue SafeStain (Invitrogen).
Protein Digestion
For digesting isolated proteins, the entire gel lanes were
cut into 30 slices, diced, and destained in 200 L 50%
(vol/vol) acetonitrile in 50 mM ammonium bicarbonate
with 10 min agitation at 4 °C. The gel pieces were then
dehydrated in 100% acetonitrile and digested with 12.5
ng/L sequencing grade modified trypsin (Promega,
Madison,WI, USA). The resulting peptides were extracted
on reverse phase resin (POROS 20 R2, Applied Biosys-
tems, Foster City, CA, USA), packed on ZipTip with C18
resin (Millipore, Billerica, MA, USA), washed twice with
20 L 0.1% (vol/vol) trifluoroacetic acid (TFA), and eluted
with 25 mg/mL 2,5-dihydroxybenzoic acid (DHB) or 2
mg/mL -cyano-4-hydroxycinnamic acid (CHCA) in 70%
(vol/vol) acetonitrile and 0.1% (vol/vol) TFA directly
onto a MALDI target. Both metal MALDI targets
(Thermo), as well as electrically-conductive magnetic
MALDI targets [10] were utilized. The in-solution diges-
tion of bovine serum albumin (BSA, 50 pmol; New En-
gland Biolabs, Ipswich, MA, USA) was performed with
0.2 g trypsin in 50 mM ammonium bicarbonate at 37 °C
for 10 h with gentle agitation.
Mass Spectrometry
Mass spectrometric analyses were performed on a
MALDI LTQ Orbitrap XL mass spectrometer (Thermo
36 LUO ET AL. J Am Soc Mass Spectrom 2010, 21, 34–46Electron, Bremen, Germany). The MALDI Duo source
configuration on the LTQ Orbitrap has been modified
from the previous model on the vMALDI LTQ instru-
ment, which incorporated a nitrogen laser with 20 Hz
firing rate, coupled to the LTQ mass spectrometer via a
fiber optic cable. The MALDI Duo source on this
configuration is equipped with a nitrogen laser MNL
100 (LTB, Berlin, Germany), operating at 337.1 nm
wavelength, with up to 60 Hz repetition rate, 75 J
maximum energy per pulse, and 3 ns pulse duration
[15]. The laser beam is focused using two adjustable flat
mirrors and a single plano-convex lens. This direct
beam configuration was designed to improve the con-
sistency and efficiency of the laser energy transmission
of the vMALDI interface. The instrument was operated
in positive mode. MALDI laser energy was set to 7–10
or 15–20 J for samples embedded in CHCA or DHB
matrices, respectively. As linear traps have limited ion
capacity, which leads to readily occurring space charge
effects and reduced mass accuracy, we performed the
MS analyses of digested proteins in the Orbitrap. MS
spectra were acquired for a mass range of up to m/z
4000 with the resolution setting 60,000 at m/z 400. For
manual mode acquisition, parameters were: automated
spectrum filter (ASF) off, 200 scans/step, automated
gain control (AGC) on, allowing storage of 5e5 ions. For
acquisition in automated mode, the parameters were:
crystal positioning system (CPS), ASF off, 3 scans/step,
and AGC on. Tandem mass spectrometric (MS/MS)
analyses were carried out by MALDI IT collision-
induced dissociation (CID) using parameters previ-
ously described for analyses on MALDI-IT (LCQ Deca
XP Plus; Thermo Electron) [24, 26] and vMALDI-LTQ
(Thermo Electron) [10] mass spectrometers. Utilized
parameters included precursor ion isolation in the lin-
ear ion trap, 4 mass units isolation width, normalized
collision energy 33%, activation q 0.25, activation time
30–300 ms. For automatic MS/MS acquisition, the mass
spectrometer was operated in a data-dependent mode
to switch between Orbitrap MS and LTQ MS/MS
analyses. The 50 most prominent ions were sequentially
isolated for CID fragmentation in the linear ion trap and
subsequently excluded for 900 s. Mass spectra were
visualized and processed in Qual Browser (ver. 2.0.7;
Thermo Fisher Scientific). Protein candidates were iden-
tified by database searching against the National Center
for Biotechnology Information nonredundant protein
database, ver. 06/10/16, using the computer algorithms
XProteo (http://www.xproteo.com) or ProFound [27].
Search parameters for MS data were species: Saccharo-
myces cerevisiae (11,105 sequences); protein mass: 0–-500
kDa; protein pI: 1–14; mixture search: auto, number of
candidates displayed: 50; enzyme: trypsin; miscleavage:
1; mass type: monoisotopic; charge state: MH; mass
tolerance: 0.02 Da; fixed modification: carbamidom-
ethylation of Cys; variable modifications: oxidation of
Met and phosphorylations on Ser, Thr, or Tyr. Candi-
date peptides were confirmed by manual or automatic
CID MS/MS analyses by assessment of the b and y ionfragments and the preferential cleavages C-terminus of
Asp and Glu [11] or N-terminus of Pro residues [12, 13].
Additional parameters used for searching MS/MS data
were precursor tolerance: 0.02 Da; fragment tolerance:
0.5 Da; instrument: MALDI_I_TRAP. All XProteo as-
signments made based on MS/MS data acquired in
automated mode were checked manually. The XProteo
probability scores, based on an improved version of the
ProFound Bayesian algorithm [27], indicate d= (discrim-
inability) values for each candidate protein as the
normalized distance between the score distribution (of
the candidate protein) and the distribution of randomly
matched proteins (in units of standard deviation). A
score of d= 4 corresponds to a true positive rate of 0.99
and a false positive rate of 0.05. While proteins with
d=  4 were readily verified by our MS/MS analyses,
several proteins with lower scores could also be con-
firmed (Supplementary Tables S3, S4, and S5).
Calibration
External calibration was performed using standard pep-
tide mixtures (ProteoMass calibration kit, Sigma) for
either the normal (m/z 150–2000) or high mass range
(m/z 200–4000). Internal calibration was performed by
enabling the lock mass option in MS mode. The trypsin
peptide LGENHIDVLEGNEQFINAAK (C96H152N27O33;
[M  H] at m/z 2211.104586) was used for internal
calibration.
Accuracy Determination
One hundred nine peptides confirmed by peptide frag-
mentation from proteins immunopurified with Nup84
were selected for determining accuracy. Immediately
following external calibration, MS were acquired as
described above, with or without the lock mass. Them/z
values of the confirmed peptides, recorded to six digits
after the decimal points, were used to calculate the mass
error (Supplementary Table S2).
Sensitivity Assay
Angiotensin II (ProteoMass Sensitivity Standard,
Sigma) was spotted onto a MALDI target with either
recrystallized CHCA or DHB as a serial dilution with
final concentration ranging from 100 fmol to 0.05 fmol.
The laser energy was set to 10 J for CHCA or 20 J for
DHB.
Resolution Assessment
Duplicate isolations of Nup84 were processed into 28
samples per gel lane and spotted using either DHB or
CHCA. MALDI Orbitrap MS of Nup84 samples were
acquired using resolution settings of 60,000 and 30,000
at m/z 400. The resolution values, as indicated in
Qual Browser (Thermo Scientific), were obtained from
26,000 peaks for each resolution setting and plotted
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sion was calculated.
Neutral Loss Scanning
Synthetic phosphorylated peptide RRLIEDAE-pY-AARG
(SRC peptide; ANA SPEC, San Jose, CA) was spotted
onto a MALDI target as a serial dilution with final
concentrations ranging from 100 to 0.25 fmol/L, as a
mixture with (1) 50 fmol/L three-peptide mixture
(des-Arg-bradykinin, neurotensin and glucagon), (2) 50
fmol/L BSA digested with trypsin, and (3) trypsin-
digested 100 kDa synthetic weight-marker (Invitrogen).
Neutral loss scanning was performed using stepwise
acquisition of parent ion scanning, precursor ion isola-
tion window of 4 Da over a m/z range of 1100–1900,
product ion width of 1 Da, 35% collision energy, and
neutral loss set at 98 Da for the loss of phosphoric
acid.
Results and Discussion
Characterizing Protein Complexes Using Affinity
Purifications and MALDI Mass Spectrometry
In previous work, we observed that MALDI mass
spectrometric configurations provide valuable tools for
analyzing the composition of isolated protein com-
plexes or larger assemblies [1–3, 24, 28]. To assess the
performance of the MALDI LTQ Orbitrap for character-
izing protein complexes, we selected as case studies two
protein assemblies that have been previously analyzed
using modular MALDI QqTOF and MALDI IT mass
spectrometers, the yeast clathrin associated protein
complex AP-2R, isolated via Apl1, and the yeast nuclear
pore Nup84 subcomplex [24]. We utilized Saccharomyces
cerevisiae yeast strains expressing endogenous levels of
Nup84 or Apl1 tagged with protein A (PrA) or en-
hanced green fluorescent protein (EGFP), respectively.
Following harvesting and cryogenic cell lysis, Apl1 and
Nup84 complexes were isolated by one-step immuno-
affinity purifications on magnetic beads coated with
antibodies against the tag, as previously reported (Sup-
plementary Figure S1A,) [24]. Custom high-affinity
anti-GFP antibodies were utilized for isolating Apl1-GFP
and IgG for Nup84-PrA. Co-isolated proteins were
resolved by 1-D gel electrophoresis (Figure 1), subjected
to trypsin digestion and deposited onto MALDI targets.
We utilized both commercially-available metal targets
and electrically-conductive magnetic targets [10], which
can be made in-house using polyethylene film coated
with indium tin oxide. Due to the elimination of the
washing and reusing steps required for the common
metal targets, the magnetic targets were amenable for
sample preservation, and, therefore, valuable for targeted
follow-up experiments. The use of magnetic targets
was an economical alternative to the metal targets,
especially when considering the numerous users and
ongoing parallel experiments. While readily incorpo-rated for manual and automatic MS and MS/MS anal-
yses, these magnetic targets were not found to be
optimal for performing instrument calibrations. One
possible explanation for this observation is the require-
ment of a stable flow of ions during the calibration
process. Factors such as differences in the crystalliza-
tion process on the two different surfaces, spot-to-spot
variations, and, occasionally, possible matrix depletion
leading to the production of polymer ions from the
plastic surface of the target, can affect the stability of ion
production. Therefore, we utilized metal targets for the
calibration and sensitivity assays, and magnetic targets
for the analyses of samples derived from isolating
protein complexes.
Resulting peptides were analyzed by MALDI MS
and MS/MS analyses using a MALDI LTQ Orbitrap
(Supplementary Figure S1B). The FTMS peptide finger-
print analyses, executed in the Orbitrap, benefited from
high accuracy and resolving power, while the LTQ
offered speed and sensitivity of detection for MALDI
LTQ CID MS/MS analyses (Figure 2, Supplementary
Figure S2, and Figure 3). Examples of MALDI CID
MS/MS spectra with detection at the linear trap or
Orbitrap levels are shown in Supplementary Figure S2.
For the Orbitrap detection, an increased number of
scans (compared with the linear trap detection) were
necessary to generate a product ion spectrum that could
confidently confirm peptide identity. However, the
accuracy and resolution provided by the Orbitrap
proved critical for resolving and detecting peptides in
complex mixtures (as described in the following sec-
tions). The peptides of interest can also be investigated
using two additional methods for ion fragmentation
available on this configuration, PQD (pulsed Q dissoci-
Figure 1. Characterization of protein complexes using the MALDI
LTQ Orbitrap. Isolation of endogenous levels of genomically-
tagged Apl1-EGFP and Nup84-PrA from yeast. The main ob-
served interacting partners are indicated and color coded accord-
ing to known (red) and putative novel (black) associations. The
colors in the Nup84 isolation illustrate the presence of multiple
subcomplexes of the yeast nuclear pore.ation) [29–31] and HCD (higher-energy C-trap dissoci-
pep
38 LUO ET AL. J Am Soc Mass Spectrom 2010, 21, 34–46ation) [32]. While not the focus of this manuscript, these
fragmentations were reported to be suitable for quan-
titative studies on the ES LTQ Orbitrap configuration
[30, 31].
Apl1 and Nup84 candidate interacting partners were
identified by database searching using the XProteo
computer algorithm and verified manually for precursor
mass errors less than 4 ppm (according to our accuracy
assessment, Figure 5), correct assignment of b and y ions,
preferential cleavages at Asp, Glu, and Pro residues, and
MS/MS confirmation of a minimum of two peptides per
protein candidate. Complete lists of identified proteins
from the three isolations are given as supplementary
material (Supplementary Tables S3 and S4).
The clathrin adaptor complex AP-2R, which links
clathrin to receptors on the membrane surface of a
coated vesicle, is a heterotetramer composed of two
large (Apl3 and Apl1), one medium (Apm4), and one
small (Aps2) subunits. Our isolation of Apl1 resulted in
the identification of all its previously reported interact-
ing partners, Apl3, Apm4, Aps2 [33, 34], and Ede1 [24]
Figure 2. Representative MALDI LTQ Orbitrap
MS shows a mixture of peptides corresponding
kDa. Examples of peptides from each protein
expanded MS regions containing Apl1 and Apl3(Figure 1, Figure 2, and Figure 3, and SupplementaryTable S3). The expression levels of the isolated proteins
were estimated in the S. cerevisiae GFP fusion protein
localization database at 1670 (Apl1), 1590 (Apl3), 1390
(Aps2), 3410 (Apm4), and 1380 (Ede1) molecules per
haploid cell [35]. Several additional proteins were co-
isolated with Apl1, such as Fks1 (expression levels
undetermined), which is involved in cell wall remodel-
ing [36] and may indicate new avenues to pursue in
further elucidating the molecular functions of Apl1. The
specificity of the new binding partners, including
Bmh2, a 14-3-3 protein reported to be involved in
exocytosis and vesicle transport [37], and Pma1, a
Plasma membrane H-ATPase [38], which are present
at higher copy number per cell (47,600 and 1260,000,
respectively), is still to be determined.
Representative MALDI LTQ Orbitrap MS and
MALDI IT CID fragmentations of [M  H] ions of
peptides from proteins co-isolated with Apl1 are pre-
sented in Figures 2 and 3, illustrating the complemen-
tary merits of the Orbitrap and linear trap. The detec-
tion of adjacent peaks was greatly assisted by the
of selected proteins co-isolated with Apl1. The
l1, Apl3, Pma1, and GFP, co-migrating at 110
beled in the spectrum. The panel insets show
tides.MS
to Ap
are laresolving power of the Orbitrap, as we could readily
39J Am Soc Mass Spectrom 2010, 21, 34–46 MALDI LTQ ORBITRAP FOR PROTEIN ASSEMBLIESFigure 3. Representative MALDI LTQ Orbitrap CID spectra of [M  H] ions of peptides from
proteins co-isolated with Apl1. The small panel insets illustrate the MS regions containing the peptides
selected for fragmentation. The corresponding monoisotopic masses are indicated. Following CID, the
generated fragment ions were detected at the linear trap level.
40 LUO ET AL. J Am Soc Mass Spectrom 2010, 21, 34–46assign peptides corresponding to Apl1, Apl3, Pma1,
and GFP in a mixture (Figure 2). As shown in Figure 3,
the MALDI CID fragmentation of singly-charged ions
provided sufficient information for the conclusive iden-
tification of peptides corresponding to Apl1 interacting
partners. We compared these results with our previous
observations from equivalent Apl1 isolations (same
sample amounts, magnetic beads, and lysis buffer),
using as a reference point the data reported from a
MALDI-QqTOF instrument [24]. To keep the data inter-
pretation consistent, we reanalyzed our results in a
similar manner with our previous study by using the
ProFound search engine [27] (Table 1). For the proteins
identified in both isolations, this comparison indicated
equivalent results in terms of protein sequence cover-
age. Several factors can contribute to this observation.
First, the possible presence of false peptide assign-
ments, as a consequence of the higher mass errors
following Q-TOF analyses (allowed for in the database
search to match the instrument performance), could
erroneously inflate the sequence coverage. Second,
given the equivalent sample amounts utilized for these
isolations, the resulting peptides were expected to be
present at similar levels. Therefore, unless peptide
recognition was obstructed by the noise level or neigh-
boring peaks in the Q-TOF experiments and aided by
the resolving power and accuracy of the Orbitrap (e.g.,
Figure 2), similar protein sequence coverage would be
expected. Third, although these isolations were carried
out under identical conditions (amount of cells and
beads, lysis buffer), some experimental variations may
still occur (e.g., during protein digestion). These factors
may also in part account for the identification of the
three proteins not observed in the Q-TOF experiment,
Fsk1, Pma1, and Bmh2. Another observation from this
comparison was that, as expected, the average absolute
mass errors of the observed peptides were significantly
improved in the MALDI LTQ Orbitrap MS analyses,
which led to improved expectation values (Table 1) and
therefore, conclusive protein identifications.
As a second test, we selected another well character-
ized protein assembly and isolated PrA-tagged Nup84,
Table 1. Equivalent Apl1-EGFP immunoisolations analyzed usin






Apl1 53% 0.003 (0.002) 1.6 
Apl3 53% 0.003 (0.002) 9.0 
Ede1 19% 0.005 (0.004) 8.5 
Apm4 58% 0.002 (0.001) 2.3 
Aps2 48% 0.003 (0.003) 6.9 
Pmd1 6% 0.006 (0.003) 2.4 
Fks1 11% 0.003 (0.001) 1.6 
Pma1 19% 0.002 (0.002) 5.0 
Bmh2 45% 0.005 (0.001) 9.7 *Protein sequence coverages (%), average absolute mass errors (Da), and exp
using a MALDI LTQ Orbitrap compared with our previous reports using a Mpresent at endogenous level in yeast cells. The nuclear
pore Nup84 subcomplex is an assembly of seven pro-
teins [39–42], Nup133, Nup120, Nup145C, Nup85,
Nup84, Seh1, and Sec13. These proteins constitute the
outer rings of nuclear pore complexes [1, 2], which are
the gatekeepers of nucleo-cytoplasmic transport. The
isolation of Nup84 yielded all the seven members of
the Nup84 subcomplex [1, 2] and several nuclear pore
proteins that were previously identified in isolations of
Nup84, such as Nup170, Nic96 [43] and Nup188,
Nup192, Nup59, Nup53, Nup57, and Nsp1 [24]. We
previously showed that this inter-subcomplex associa-
tion with members of the Nup170 subcomplex, which is
weaker than the intra-subcomplex interactions between
the seven members of the Nup84 subcomplex, is pre-
served by using short times of incubation with mag-
netic beads (e.g., 30 min or less) [24]. Additionally, we
found other members of the nuclear pore complex,
including Nup49, Nup82, and Nup159. As demon-
strated in a recent detailed study of the architecture of
the nuclear pore complex [1, 2], these proteins are
present in subcomplexes neighboring the Nup84 sub-
complex. Figure 1 illustrates the identified proteins
isolated with Nup84-PrA, color coded according to
their affiliated subcomplexes (Figure 1 and Supplemen-
tary Table S4) [1, 2]. Supplementary Table S4 presents a
complete list of the identified proteins, classified ac-
cording to their affiliation to structural subunits of the
nuclear pore complex, or proteins that we and others
[25, 44] have observed as common contaminants in
isolations from yeast cell extracts. A direct comparison
between results obtained from the MS analyses of the
same samples using manual and automatic modes of
acquisition demonstrated that these experiments can be
carried out in a high-throughput manner (Supplemen-
tary Table S4). Similarly, MS/MS analyses performed in
automated mode can benefit from the accurate selection
of the peaks via a pre-scan of the ion population in the
Orbitrap. While these experiments provided promising
results, we asked how these findings translate in terms
of basic instrument performance and seek to character-
ize the resolving power and mass accuracy in the






47% 0.017 (0.012) 1.6  106
5 46% 0.016 (0.016) 2.4  109
23% 0.022 (0.016) 6.8  1010
9 51% 0.011 (0.013) 1.6  1014
45% 0.014 (0.011) 9.2  105













106ectation values (ProFound) are shown for interacting partners detected
ALDI QqTOF [24]; n/o  not observed.
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complexes. The ability to resolve and detect peptides
within mixtures is critical when using mass fingerprint-
ing for identifying or quantifying peptides and post-
translational modifications. This is equally true when
studying isolated protein assemblies, where the com-
plexity and stoichiometry of protein components can
present challenges for their detection. Therefore, we
asked what the distribution of the Orbitrap resolving
power over the full mass range is for analyzing mix-
tures of peptides present at various levels.
Dynamic Range of Resolution in the m/z
200–4000 Range
While the MALDI LTQ Orbitrap XL allows spectra
acquisition in the Orbitrap at a maximum resolving
power of 100,000 at m/z 400, we routinely employ a
resolution setting of 60,000 at m/z 400 for peptide
analysis as a compromise between scanning speed (0.9 s
per scan cycle) [20] and resolving power. For high-
throughput analyses, where scanning speed is critical, a
lower resolution setting of 30,000 (0.5 s per scan cycle)
may be preferred. As the majority of the MALDI-
generated singly-charged peptide ions that we select for
protein characterization usually range between m/z 600
and 4000, we performed the assessment of the resolu-
tion and its dynamic range over the full mass range (up
to m/z 4000). To render this information accurate for the
analysis of isolated protein assemblies, we performed
these measurements using samples from immunopuri-
fied Nup84 protein complexes (Figure 1). The measured
resolution values were plotted as a function of m/z and
dynamic range, the colored heatmap indicating the
relative peak intensities (Figure 4 and Supplementary
Figure S3). The obtained data were divided into three
categories according to peak intensity, and illustrated
separately (Figure 4). Several observations were made
from these plots. First, in agreement with the prediction
from the theoretical model [16, 45], the experimental
resolution values for these complex peptide mixtures
were inversely proportional to the square root of m/z
(Figure 4c). Second, over the full m/z 200–4000 range,
the vast majority of peaks had resolutions above 20,000
or 10,000 for resolution settings of 60,000 or 30,000 at
m/z 400, respectively. For example, at the setting of
60,000 at m/z 400, peaks had resolutions above 40,000 at
m/z 1000, above 30,000 at m/z 2000, and above 20,000 at
m/z 4000. This enabled a clear determination of peptide
isotopic distributions and separation of neighboring
peaks in these peptide mixtures. Third, peaks of various
intensities, ranging over four to five orders of magni-
tude, had resolutions that obey a similar trend (Figure
4a and b). This is consistent with the previously re-
ported three orders of magnitude of dynamic range for
accuracy for ions below m/z 2000 [46]. An alignment of
the resolution pattern for the different peak intensities
and examples of spectra are given as supplementarymaterial (Supplementary Fig. S3). Fourth, a few data
points deviated from the curve. These seem to partially
derive from spectra complexity (overlapping peaks) or
background chemical noise.
Effects of External and Internal Calibrations on
Mass Accuracy Over the Full m/z Range
Internal calibrations (e.g., polycyclodimethylsiloxane
and MRFA peptide) have been reported to improve the
accuracy and reduce the calibration drift on the ES LTQ
Orbitrap configuration [19, 20]. MALDI mass spectrom-
eters provide an innate ease for implementing internal
calibrations due to the constant presence of ions corre-
sponding to matrix clusters and trypsin autolysis frag-
ments [43]. We tested external and internal calibrations
for improved mass accuracy of measurements of pep-
tides from the isolated Nup84 subcomplex. External
calibrations were carried out using two peptide mix-
tures for the normal (less than m/z 2000) and high (up to
m/z 4000) mass ranges. For internal calibration, well
characterized trypsin autolysis peptides [47] were used
as lock masses. The use of a single lock mass proved
sufficient for improved accuracy, as we illustrated for
the m/z 2211.104586 trypsin autolysis peak (Figure 5).
The mass errors of 109 MS/MS-confirmed peptides
from proteins co-isolated with Nup84 (Supplementary
Table S2), with m/z values ranging from 800 to 3700,
were used to evaluate the resulting accuracy following
external or internal calibrations. The absolute mass
error was plotted against m/z (Figure 5a). External
calibration resulted in an average mass error and stan-
dard deviation of 1.02  0.73 ppm, with nearly 90%
(97/109) of measurements having 2 ppm mass errors
and 10% falling within the range of 2–3.5 ppm. As
previously reported for the ES LTQ Orbitrap [20], we
observed a long-term stability of mass measurements
with external mass calibration, which remains stable
within 3 ppm for 3 d (data not shown). Internal calibra-
tion using the trypsin autolysis peptide further im-
proved accuracy, leading to a smaller average mass
error and a tighter error distribution of 0.50  0.54 ppm
(P values  0.001 and 0.01, respectively). Moreover, the
distribution of mass error with external calibration was
centered at 1 ppm (Figure 5b), implicating a small
systematic error that may be caused by other factors,
such as temperature instability [19] and space charge
effects [48]. The ability to prevent space charge effects is
challenging for MALDI experiments, where the shot-to-
shot variation can drastically affect the ion yield [49].
The automatic gain control (AGC), used for controlling
ion flux, can reduce space charge effects and was
reported to achieve the target range of number of
charges for the majority (95%) of data acquisitions
[15]. Our results indicated that the internal calibration
can compensate for the systematic shift that may be
caused by such factors, leading to a distribution of mass
accuracy centered at 0 ppm. Although we have not
42 LUO ET AL. J Am Soc Mass Spectrom 2010, 21, 34–46tested other internal calibrants, matrix cluster ions may
also be a suitable option [47].
Sensitivity Using DHB and CHCA Matrices
The ability to detect and identify peptides present at
various levels within complex mixtures relies on the
sensitivity of the instrument. While the sensitivity pro-
Figure 4. The resolving power of MALDI-LTQ
intensity. Resolution values measured from MS
against m/z. Results are shown for spectra acqui
The colors of the data points indicate relative
measurements, was split according to the peak in
categories and plotted separately. The peak inten
color bars illustrate the corresponding intensity
tion of the observed peaks. The parameters of th
summarized in (c).vided by a ES LTQ Orbitrap configuration was reportedat femtomole levels [20, 50], the concentration of the
utilized matrix sensitivity will be critical for achieving
optimal sensitivity when using a MALDI mass spec-
trometer [51, 52]. As the use of different matrices for
MALDI MS and MS/MS analyses can be advantageous
in accommodating various samples, we assessed the
optimal concentrations of two matrices that we most
commonly use for peptide analysis, CHCA and DHB.
itrap XL as a function of m/z and relative peak
ra of the isolated Nup84 samples were scattered
t resolution settings of 60,000 (a) and 30,000 (b).
k intensity. Each dataset, containing 26,000
ity into “top 1/3”, “middle 1/3”, and “low 1/3”
s were drawn to the same scale for all plots. The
es, while the histograms represent the distribu-







e corTable 2 illustrates the reproducibility of the mass spec-
t pan
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serial dilution of 0.05 to 25 fmol Angiotensin II in
different concentrations of CHCA or DHB matrices.
Both matrices provided subfemtomole sensitivity when
analyzing this single peptide, with a higher sensitivity
of detection for decreased matrix concentrations. These
matrix concentrations were optimized for the detection
of a single peptide. The comprehensive characterization
of complex peptide mixtures, such as those resulting
from the isolation of protein complexes, requires longer
acquisition times. For such studies, 2 mg/mL for CHCA
and 20 mg/mL for DHB provide a balance between
sensitivity and slower sample depletion.
We next inquired about the sensitivity of detecting
phosphorylation sites, an important aspect of character-
izing protein complexes and understanding biological
processes. To render this information relevant for ana-
Figure 5. Characterization of the mass accura
peptides were calculated from externally (dar
calibrated MS spectra of proteins co-isolated wi
plotted against the m/z of the peptides (left pan
as a histogram with bin width of 0.5 ppm (righ
Table 2. Effects of matrix type and concentration on sensitivity
Angiotensin II (fmol) 0.05











5 mg/mL Detection levels of Angiotensin II peptide (DRVYIHPF, m/z 1046.5423) are ill
various concentrations of (A) CHCA and (B) DHB matrices.,, and inlyzing peptide mixtures, we selected a synthetic phos-
phorylated peptide and analyzed it using neutral loss
scanning within mixtures of increased complexity. We
analyzed a series dilution of the tyrosine phosphory-
lated SRC peptide RRLIEDAEpYAARG. Following
analyses of the pure sample, the peptide was mixed
with standard peptides (calibrants), tryptic peptides
from BSA, or the 100 kDa molecular weight marker to
increase spectra complexity. MS2 and MS3 analyses
were used to confirm the identity of the phosphorylated
peptide (Supplementary Figure S4). It is noteworthy
that the collision-induced dissociation of the phosphor-
ylated SRC peptide, in contrast to the usual loss of the
metaphosphoric acid (HPO3, 80 Da) for pTyr-peptides,
led to a more abundant [M  H  98] ion (Supple-
mentary Figure S4). A neutral loss of phosphoric acid
(H3PO4, 98 Da) was previously reported for the same
the MALDI LTQ Orbitrap. Mass errors of 109
ue points) or internally (light pink triangles)
p84. (a) The absolute values of mass errors are
he distribution of the real mass errors is shown
el). (b) Summary of mass error statistics.
bitrap detection
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ustrated for single scan MALDI LTQ Orbitrap FTMS acquisitions using
dicate the reproducibility of the detection from a triplicate experiment.
alibr
ndica
44 LUO ET AL. J Am Soc Mass Spectrom 2010, 21, 34–46phosphotyrosine-containing SRC peptide and shown to
be dependent on the presence of the arginine and
aspartic acid residues [53]. The proposed mechanism
involved a transfer of the phosphate group from ty-
rosine to aspartic acid, with following cleavage of
H3PO4 via succinimide formation [53]. A recent study
[54] has investigated this interesting loss of H3PO4 from
singly deprotonated phosphotyrosine-peptides during
Q-TOF and IT CID, demonstrating that this elimination
occurs from an intramolecular relocation of the pTyr
phosphate, and not the consecutive losses of HPO3 and
water. Our MALDI CID MS2 of the pTyr-peptide was
consistent with these previous reports, as the loss of 98
Da was the most prominent fragment detected, the 80
Da loss being close to noise level. Therefore, we selected
the ion corresponding to the neutral loss of 98 Da for
assessing the sensitivity achieved using neutral loss
scanning. Our results showed that this ion was detected
following CID fragmentation of as low as 0.5 fmol of
SRC peptide (Table 3). A limitation in implementing
neutral ion scanning is the lengthy duration of anal-
ysis and, consequently, consumption of a large
amount of sample. Therefore, as a general practice,
when implementing neutral ion scanning in studies
of other isolated protein complexes (where phosphor-
ylation played important regulatory roles), we per-
formed these analyses after the initial identification of
the proteins present within those samples (data not
shown).
Conclusions
Resolution, accuracy, and sensitivity are key features of
the performance of a mass spectrometric instrumenta-
tion, defining the achievable depth in characterizing
complex biological samples. Here, we determined the
performance of the MALDI LTQ Orbitrap configuration
for analyzing the composition of isolated protein com-
plexes. As illustrated for the isolations of Apl1 and
Nup84, the combination of resolving power, accuracy,
and sensitivity greatly improved the detection of co-
isolated proteins present at various levels, inherent of
the complex stoichiometry, or as part of neighboring
subcomplexes. Our assessment of the Orbitrap resolv-
ing power by measuring 20,000 peptides from these
isolated protein complexes demonstrated, to our knowl-
Table 3. Sensitivity of detection of the phosphorylated RRLIED
Concentration of pSRC
peptide (fmol/L) 0.25 0.5 1.0
pSRC  50 fmol/L calibrants  
pSRC  50 fmol/L BSA  
pSRC  100 kDa marker  
Detection levels are shown for pSRC peptides as amixture with 50 fmol c
BSA, and 50 fmol in-gel trypsin digested 100 kDa marker;  symbols iedge for the first time using large-scale experimentaldata up to m/z 4000, that the resolution is a function of
the square root of m/z as previously predicted [16, 45],
and has a dynamic range of over four orders of magni-
tude. This dynamic range is valuable for detecting
peptides with reduced ionization efficiencies or present
at low levels. As the MALDI mass spectrometers are
easily amenable to the implementation of internal cali-
brations [43], we utilized a tryptic autolysis peak as mass
lock and showed an improved accuracy to 0.5 ppm
absolute mass error with centered mass error distribution.
In addition, subfemtomole sensitivity was achieved using
both CHCA and DHB matrices in a matrix concentration-
dependent manner. These results indicate that theMALDI
LTQOrbitrap is well suited for studies of protein complex
composition, re-emphasizing the value of MALDI config-
urations for such analyses.
In terms of analyzing isolated protein complexes, the
enhanced sensitivity of the current mass spectrometric
methods has led to a lower threshold of detection and
the identification of an increased proportion of co-
isolated proteins. While this is desired and necessary
for comprehensive studies of protein assemblies or
cellular compartments, these analyses also highlighted
the increasing need for improved methodologies for
clean and robust isolations of protein complexes. The
isolation of protein complexes is usually accompanied
by nonspecific associations present at various levels, as
well as indirect associations of neighboring complexes,
which are increasingly detectable with the current sen-
sitivity (e.g., the immunoaffinity purification of Nup84).
The choice of antibodies, resin used for affinity purifi-
cations, and time of incubation of the cell lysate with
resin can critically affect the levels of contaminations
observed. Nonspecific associations may not only derive
from the direct binding to the resin or antibodies
utilized, but also from binding to the isolated protein
complex. Purified proteins can act as new interacting
sites for numerous proteins present in the cell lysate
(e.g., abundant cytoskeletal and ribosomal proteins)
during the isolation process. This can interfere with the
interpretation of the results in terms of pursuing spe-
cific protein function. Incorporation of strategies that
result in clean isolations, such as fast (minutes) immu-
noaffinity purifications [28] and two-step isolations
(e.g., [55, 56]), or that allow distinguishing specific and
nonspecific interactions (e.g., differential labeling with
AARG (pSRC) peptide using neutral loss scanning
.5 5.0 10 25 50 100
     
     
     
ant (ProteoMass vMALDI calibrant, Sigma), 50 fmol in-solution digested




stable isotopes, I-DIRT [44]), are a necessity.
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